SI earnings date and last-quarter result: next report 2026-09-08, last quarter beat, P/E -9.36. Updated 2026-07-23.
Shoulder Innovations (SI) Research Hub
Shoulder Innovations (SI) trades on NYSE, US in the Healthcare (Medical - Specialties) sector. As of 2026-10-26, shares last closed at 19.38 USD (-1.42%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E -9.36, market cap 0.41B. This hub links to the full technical, earnings and options research available for SI.
Last updated 2026-10-26 · Source: end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Medical - Specialties) |
|---|---|
| Exchange | NYSE, US |
| Last close | 19.38 USD (-1.42%) |
| 52-week range | 16.56 USD – 24.6 USD |
| Trend regime | Range |
| 14-day RSI | 52.5 (Neutral) |
| Trailing P/E | -9.36 |
| Market cap | 0.41B |
| Dividend yield | 0.00% |
| Next earnings | 2026-09-08 |
Available research for SI
Covered Call on SI: how it works, illustrative setup around the real 19.38 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on SI: how it works, illustrative setup around the real 19.38 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on SI: how it works, illustrative setup around the real 19.38 USD price, max profit/loss, breakeven and when to use it. Educational.
SI technical analysis: range, last 19.38 USD, RSI 52.5, 52w range 16.56 USD–24.6 USD, real support/resistance. Updated 2026-10-26.
More on SniperIQ
Frequently asked questions
What sector is SI in?
Shoulder Innovations (SI) is classified under Healthcare (Medical - Specialties), listed on NYSE, US.
Is SI in an uptrend or downtrend?
As of 2026-10-26, SI is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is SI's trailing P/E ratio?
SI's trailing P/E is -9.36, with a market cap of 0.41B. See the earnings research page for full valuation detail.
When does SI next report earnings?
SI is next scheduled to report earnings on 2026-09-08.